Challenges of frequent blood transfusion
Infection risks in modem blood transfusion have been severely minimized but not eliminated
altogether.
However, the main problem in this condition is the iron overload which is inevitable
with repeated transfusions. Excess iron is deposited in major vital organs - including
the heart, liver and pancreas - slowly damaging them. Eventual failure of these organs,
especially the heart, leads to death.
Tackling iron overload in thalassemia
There are various forms of medication used to combat this, so far with mixed success.
Looking for alternatives to blood transfusion in thalassemia Major
To circumvent blood transfusion, bone marrow transplants have been used, occasionally
(but not always) with success. The best chance is produced by the availability of
a matching donor, especially if it is a sibling. Not all siblings will match.
Gene therapy and Thalassemia
Research is still going on into the possibility of gene replacement therapy in thalassemia.
In September 2010, the science journal Nature published a report of a breakthrough
in this regard. This was a case report of a teenager who had Thalassemia major and
who had been on monthly blood transfusion since the age of three. At 15 he had stem
cells extracted from his bone marrow and these cells underwent the very complex process
of introducing a normal gene using a lentoviral vector. The modified cells were then
transplanted back into his body. A year after the transplant he stopped requiring
transfusions with his blood count remaining stable. At the time of publishing the
report he had been two years without requiring a transfusion. This was the first
success of its kind. Let’s not get carried away. Huge hurdles remain to perfect the
technology but this offers real promise and it is, potentially, a pivotal breakthrough
in the search for a cure.
Pregnancy for a Thalassemia Major patient
For a young woman with Thalassemia Major, pregnancy is a formidable proposition.
The general health of these girls means that they would have difficulty conceiving
and the wisest counsel for most of them would be to avoid pregnancy. This is based
on the fact that their already compromised vital organs (especially the heart) may
fail completely under the added strain of pregnancy. There have only been a handful
of reported cases of successful pregnancies in girls with Thalassemia Major.
Does the above imply that most Thalassemia-affected prenatal patients will only be
carriers?
Yes. As mentioned earlier, Thalassemia minor is a condition compatible with good
general health. However, in pregnancy, there is a tendency to suffer anemia and,
if the carrier status was undiagnosed until then, the anemia may trigger the definitive
diagnostic tests which will confirm the diagnosis for the first time.
Treatment for anemia in Thalassemia minor
To some degree, the anemia treatment is quite similar to everybody else’s. While
in Thalassemia major, the administration of iron supplements is absolutely contraindicated,
in Thalassemia minor, iron may be given. This is because these individuals rarely
need transfusions and therefore the risk of iron overload is minimal or non-existent.
However, as a precaution, many experts advise a test to check the levels of iron
reserves in the body.
Injectable Iron in Thalassemia Minor
Iron by injection cannot be used in Thalassemia minor. If the woman is completely
unable to tolerate all forms of oral iron supplements, other ways of supplying her
with iron - which may be dietary - have to be sought, if definitely required.
Labor and delivery in Thalassemia: Next Page